PHARMATHENE, INC 4
4 · PHARMATHENE, INC · Filed Jan 9, 2015
Insider Transaction Report
Form 4
CHANG LINDA L
SVP & CFO
Transactions
- Sale
Common Stock, $0.0001 par value per share
2015-01-07$2.10/sh−29,600$62,160→ 30,000 total - Exercise/Conversion
Common Stock, $0.0001 par value per share
2015-01-07$1.13/sh+29,600$33,448→ 59,600 total - Exercise/Conversion
Option to Purchase
2015-01-07−29,600→ 45,400 totalExercise: $1.13Exp: 2022-12-03→ Common Stock (29,600 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2014.
- [F2]These shares were sold in multiple transactions all at the same price of $2.10 per share.
- [F3]These options were part of a grant of 75,000 options on 12/03/2012, which vest 25% on each of the first, second, third and fourth anniversaries of the grant date.